These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 19500982

  • 41. Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H₁-antihistamines for insomnia.
    Ravula SB, Yu J, Tran JA, Arellano M, Tucci FC, Moree WJ, Li BF, Petroski RE, Wen J, Malany S, Hoare SR, Madan A, Crowe PD, Beaton G.
    Bioorg Med Chem Lett; 2012 Jan 01; 22(1):421-6. PubMed ID: 22153347
    [Abstract] [Full Text] [Related]

  • 42. Melanin-concentrating hormone receptor 1 antagonists: synthesis, structure-activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives.
    Kasai S, Kamaura M, Kamata M, Aso K, Ogino H, Nakano Y, Watanabe K, Kaisho T, Tawada M, Nagisa Y, Takekawa S, Kato K, Suzuki N, Ishihara Y.
    Bioorg Med Chem; 2011 Nov 01; 19(21):6261-73. PubMed ID: 21975069
    [Abstract] [Full Text] [Related]

  • 43. Substituted chromones and quinolones as potent melanin-concentrating hormone receptor 1 antagonists.
    Dyck B, Zhao L, Tamiya J, Pontillo J, Hudson S, Ching B, Heise CE, Wen J, Norton C, Madan A, Schwarz D, Wade W, Goodfellow VS.
    Bioorg Med Chem Lett; 2006 Aug 15; 16(16):4237-42. PubMed ID: 16762549
    [Abstract] [Full Text] [Related]

  • 44. Melanin concentrating hormone receptor antagonists as antiobesity agents: from M2 to MCHR-1.
    McBriar MD.
    Curr Top Med Chem; 2007 Aug 15; 7(15):1440-54. PubMed ID: 17897031
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Design, synthesis, and pharmacological evaluation of piperidin-4-yl amino aryl sulfonamides: novel, potent, selective, orally active, and brain penetrant 5-HT₆ receptor antagonists.
    Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P.
    J Med Chem; 2012 Nov 08; 55(21):9255-69. PubMed ID: 23006002
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. The design and synthesis of potent and cell-active allosteric dual Akt 1 and 2 inhibitors devoid of hERG activity.
    Siu T, Li Y, Nagasawa J, Liang J, Tehrani L, Chua P, Jones RE, Defeo-Jones D, Barnett SF, Robinson RG.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):4191-4. PubMed ID: 18550373
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Synthesis and structure-activity relationships of piperidine-based melanin-concentrating hormone receptor 1 antagonists.
    Wu WL, Burnett DA, Spring R, Qiang L, Sasikumar TK, Domalski MS, Greenlee WJ, O'Neill K, Hawes BE.
    Bioorg Med Chem Lett; 2006 Jul 15; 16(14):3668-73. PubMed ID: 16690312
    [Abstract] [Full Text] [Related]

  • 53. Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice.
    Ito M, Ishihara A, Gomori A, Egashira S, Matsushita H, Mashiko S, Ito J, Ito M, Nakase K, Haga Y, Iwaasa H, Suzuki T, Ohtake N, Moriya M, Sato N, MacNeil DJ, Takenaga N, Tokita S, Kanatani A.
    Eur J Pharmacol; 2009 Dec 10; 624(1-3):77-83. PubMed ID: 19836369
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Structure-based design of novel melanin-concentrating hormone receptor-1 ligands based on saturated nitrogen-containing heterocycles.
    Helal MA, Chittiboyina AG, Avery MA.
    Bioorg Med Chem Lett; 2023 Mar 15; 84():129194. PubMed ID: 36813053
    [Abstract] [Full Text] [Related]

  • 56. Novel pyrrolidine melanin-concentrating hormone receptor 1 antagonists with reduced hERG inhibition.
    Fox BM, Natero R, Richard K, Connors R, Roveto PM, Beckmann H, Haller K, Golde J, Xiao SH, Kayser F.
    Bioorg Med Chem Lett; 2011 Apr 15; 21(8):2460-7. PubMed ID: 21414780
    [Abstract] [Full Text] [Related]

  • 57. Identification of melanin-concentrating hormone receptor and its impact on drug discovery.
    Saito Y, Maruyama K.
    J Exp Zool A Comp Exp Biol; 2006 Sep 01; 305(9):761-8. PubMed ID: 16902961
    [Abstract] [Full Text] [Related]

  • 58. Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2.
    Hudson S, Kiankarimi M, Rowbottom MW, Vickers TD, Wu D, Pontillo J, Ching B, Dwight W, Goodfellow VS, Schwarz D, Heise CE, Madan A, Wen J, Ban W, Wang H, Wade WS.
    Bioorg Med Chem Lett; 2006 Sep 15; 16(18):4922-30. PubMed ID: 16824755
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.